Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
European Journal of Pain (London, England)|March 15, 2020
GABAergic modulation of secondary hyperalgesia: A randomized controlled 4-way crossover trial with the α2-subunit preferring GABA positive allosteric modulator, N-desmethyl-clobazam in healthy volunteersAlain Matthey, Youssef Daali, François Curtin, et al.
Plos One|April 5, 2013
Evaluation of anti-hyperalgesic and analgesic effects of two benzodiazepines in human experimental pain: a randomized placebo-controlled studyPascal H Vuilleumier, Marie Besson, Jules Desmeules, et al.
Revue Medicale Suisse|June 23, 2021
[Activity, decentration and cognitive restructuring in cognitive-behavioural therapy - practice-based aspects]Alain Souche, Valérie Piguet, Marie Besson, et al.
Fluids and Barriers of the CNS|October 28, 2024
[11C]Metoclopramide PET can detect a seizure-induced up-regulation of cerebral P-glycoprotein in epilepsy patientsMyriam El Biali, Louise Breuil, Matthias Jackwerth, et al.
Clinical and Translational Science|May 3, 2024
St. John's wort extract with a high hyperforin content does not induce P-glycoprotein activity at the human blood-brain barrierMyriam El Biali, Michael Wölfl-Duchek, Matthias Jackwerth, et al.
Pain|April 1, 1992
Chronic pain induces a paradoxical increase in growth hormone secretion without affecting other hormones related to acute stress in the ratBernard Calvino, Jean-Marie Besson, Françoise Mounier, et al.
BMJ Open|November 5, 2020
TOP-ID: a Delphi technique-guided development of a prescription and deprescription tool for adults with intellectual disabilitiesSophie Lonchampt, Fabienne Gerber, Jean-Michel Aubry, et al.
Basic & Clinical Pharmacology & Toxicology|May 28, 2011
A randomized, controlled trial validates a peripheral supra-additive antihyperalgesic effect of a paracetamol-ketorolac combinationKuntheavy Ing Lorenzini, Marie Besson, Youssef Daali, et al.
European Journal of Pain (London, England)|February 16, 2020
Pain interventions in adults with intellectual disability: A scoping review and pharmacological considerationsSophie Lonchampt, Fabienne Gerber, Jean-Michel Aubry, et al.
Frontiers in Psychiatry|July 12, 2021
Prevalence of Polypharmacy and Inappropriate Medication in Adults With Intellectual Disabilities in a Hospital Setting in SwitzerlandSophie Lonchampt, Fabienne Gerber, Jean-Michel Aubry, et al.
Pageof 10